CNS Refresh: Boehringer's New Approach To Tricky Neuropsychiatry Diseases

Doctor
Boehringer believes advances in CNS scientific understanding mean pharma needs a new approach • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Neurological

More from Therapeutic Category